Dry eye therapy

Abstract

Dry eye therapy is a challenging task for the ophthalmologist. Advances in our understanding of the risk factors, etiology and pathophysiology of dry eye have led to further development of treatment strategies. Prior to initiation of therapy, the correct classification into aqueous-mucinous tear film dysfunction (hyposecretion), lipid-related tear film dysfunction (hyperevaporative form due to abnormal meibomian gland physiology), or a variable combination of both is essential. Taking into account current recommendations of the DOG, BVA and TFOS DEWS II subcommittee, a treatment algorithm was developed that represents a stepwise approach depending on the severity of the disease.